Genpact (Genpact) Cash And Cash Equivalents : $584 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Genpact Cash And Cash Equivalents?

Genpact's quarterly cash and cash equivalents increased from Jun. 2023 ($491.31 Mil) to Sep. 2023 ($541.00 Mil) and increased from Sep. 2023 ($541.00 Mil) to Dec. 2023 ($583.67 Mil).

Genpact's annual cash and cash equivalents declined from Dec. 2021 ($899.46 Mil) to Dec. 2022 ($646.77 Mil) and declined from Dec. 2022 ($646.77 Mil) to Dec. 2023 ($583.67 Mil).

Genpact Cash And Cash Equivalents Historical Data

The historical data trend for Genpact's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genpact Cash And Cash Equivalents Chart

Genpact Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

467.10

680.44

899.46

646.77

583.67

Genpact Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															646.77	552.28	491.31	541.00	583.67

Genpact Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Genpact (NYSE:G) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Genpact Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Genpact's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Genpact (Genpact) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Genpact Ltd (NYSE:G) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

35G:Germany

Address

22 Victoria Street, Canon's Court, Hamilton, BMU, HM 12

Website

https://www.genpact.com

Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. The company is a General Electric spin-off, which is still a large source of revenue for Genpact.

Executives

Kathryn Vanpelt Stein	officer: Senior Vice President	40 WEST 24TH STREET, APT 3N, NEW YORK NY 10010
N. V. Tyagarajan	officer: Executive Vice President	825 EIGHTH AVENUE, NEW YORK NY 10019
Michael Hal Weiner	officer: Chief Financial Officer	C/O NGHC, 59 MAIDEN LANE, 38TH FLOOR, NEW YORK NY 10038
Donald J Klunk	officer: Chief Accounting Officer	3585 GRAY FOX DR, CHALFONT PA 18914
Piyush Mehta	officer: Senior VP , Human Resources	825 EIGHTH AVENUE, NEW YORK NY 10019
James C. Madden	director	825 EIGHTH AVENUE, NEW YORK NY 10019
Cecelia Morken	director	26025 MUREAU ROAD, CALABASAS CA 91302
Heather White	officer: SVP & General Counsel	1155 AVENUE OF THE AMERICAS, 4TH FLOOR, NEW YORK X1 10036
Stacey Cartwright	director	34 ROEDEAN CRESCENT, LONDON X0 SW15 5JU
Brian Mark Stevens	director	25 HOOPER HILL RD., NEW BOSTON NH 03070
Ajay Agrawal	director	105 ROBERT STREET, TORONTO A6 M5S 2K5
Tamara Franklin	director	107 STONE CLIFF ROAD, PRINCETON NJ 08540
Balkrishan Kalra	officer: Senior Vice President	5 MARION AVENUE, SHORT HILLS NJ 07078
Carol Lindstrom	director	5994 SILVERADO TRAIL, NAPA CA 94558
Darren Saumur	officer: Senior Vice President	125 DUPONT STREET, TORONTO A6 M5R 1V4